Skip to content
GLP-1 Scorecard
Menu
Site position #316

Curve

Published by GLP-1 ScorecardUpdated

Curve (Try Curve LLC) is a telehealth platform offering compounded semaglutide and tirzepatide, prescribed by Beluga Health providers licensed in all 50 states and dispensed by VialsRx, a US 503A compounding pharmacy.

Visit CurveWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$175/mo (compounded)
Tirzepatide
$225/mo (compounded)
Coverage
All 50 states
Brand-name
Not confirmed

Weigh Curve against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value58/100
Dose & formulation64/100
Clinical oversight68/100
Labs & monitoring52/100
Fulfillment97/100
Contract terms20/100

Strengths

  • Offers both compounded semaglutide and tirzepatide, with every dose priced the same so cost does not rise as you titrate up.
  • LegitScript-certified (seal #51079066) and names both its 503A compounding pharmacy, VialsRx, and its provider network, Beluga Health.
  • Transparent tiered pricing with a real month-to-month option; consultation, medication, and free expedited shipping included, no membership.
  • Available in all 50 states with same-day provider review; no insurance needed and HSA/FSA accepted.

What to consider

  • Very new (2026 launch) with a thin track record; the site still shows a Webflow template credit and a leftover Cora reference in its Terms.
  • The cheapest headline rates ($99 semaglutide / $135 tirzepatide) require a 12-month prepay; true month-to-month is $175 and $225.
  • Both product pages currently display an out-of-stock status, so availability may be inconsistent.
  • Compounded medications are not FDA-approved or therapeutically equivalent to Ozempic, Wegovy, Mounjaro, or Zepbound.

Bottom line — Grade C

Best for: Shoppers who want compounded semaglutide or tirzepatide with flat per-dose pricing, LegitScript-certified, all 50 states.

Site position #316 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest Curve — the realistic shortlist.

The 18 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Curve's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Curve's site. Not medical advice; see our disclosure.

← Back to the scorecard